Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Testing a wireless brain oxygen sensor for babies in intensive care

Tests a wireless forehead sensor in newborns in intensive care.

Plain-language title generated from the registry record
Registry title: Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit

Key facts

Where
Montreal, CanadaSee the site

Where in Canada

  • Montreal Children's HospitalMontreal, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
McGill University Health Centre/Research Institute of the McGill University Health Centre
Trial code
NCT07732244
Record updated
28 July 2026
Original description
The wireless NIRS sensor will be placed on the participant's forehead, directly underneath the INVOS wired sensor. The wireless NIRS sensor will remain in place for 4 consecutive hours, over 2 consecutive days. As standard-of-care, nursing personnel removes all sensors at every care to evaluate skin and reduce the risk of pressure sores. The wireless NIRS device will be removed and reapplied at the same time, by the research team who will annotate what time the sensor was removed, replaced, and the condition of the skin. This will be used to correlate signal disconnection with sensor care (i.e., skin checks, sensor removal, etc.).Read full original descriptionShow less

Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit: a Sub-study of the Wireless NICU Study

The wireless NIRS sensor will be placed on the participant's forehead, directly underneath the INVOS wired sensor. The wireless NIRS sensor will remain in place for 4 consecutive hours, over 2 consecutive days. As standard-of-care, nursing personnel removes all sensors at every care to evaluate skin and reduce the risk of pressure sores. The wireless NIRS device will be removed and reapplied at the same time, by the research team who will annotate what time the sensor was removed, replaced, and the condition of the skin. This will be used to correlate signal disconnection with sensor care (i.e., skin checks, sensor removal, etc.).

Inclusion: Infants admitted to the NICU with a gestational age of ≥ 32 weeks at the time of the monitoring; undergoing monitoring with the INVOS wired NIRS system.

Exclusion: Infants with a skin abnormality that would potentially increase the risk of injury,; Patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment.

ClinicalTrials.gov NCT07732244